N NUAGE THERAPEUTICS Logo (EUIPO, 11/21/2022)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark N NUAGE THERAPEUTICS was filed as Figurative mark on 11/21/2022 at the European Union Intellectual Property Office.
It was registered as a trademark on 04/13/2023.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#One circle #Circles with inscriptions projecting beyond the circumference #Circles with dark surfaces or parts of surfaces #One letter #Letter 'N'
| Trademark form | Figurative mark |
| File reference | 018797416 |
| Application date | November 21, 2022 |
| Publication date | January 4, 2023 |
| Entry date | April 13, 2023 |
| Expiration date | November 21, 2032 |
Trademark owner
Parc Científic de Barcelona, Baldiri Reixac 10-12
08028 Barcelona
ES
08028 Barcelona
ES
Trademark representatives
Arabellastr. 30
81925 München
DE
goods and services
1
Chemicals for use in science, scientific research and for laboratory use; Analytical and diagnostic reagents for in vitro use, other than for medical or veterinary purposes
5
Pharmaceutical and veterinary preparations; Chemical, analytical and diagnostic reagents for in vitro use, for medical use or For veterinary use; Chemicals for use in medical research, and medical or veterinary diagnosis; Pharmaceutical preparations for use in the treatment of cardiovascular diseases and disorders; Pharmaceutical preparations for the treatment of ophthalmic diseases and conditions, and for the treatment of inflammation and inflammatory diseases and disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders; pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical and medical preparations and substances
40
On-demand production of cell lines for use in the manufacture of biopharmaceuticals; Protein fabrication, production, and manufacture for others; Custom manufacture of pharmaceuticals; Custom manufacture of biopharmaceuticals
42
Scientific, medical and industrial research and development services; Clinical research; Research laboratories; Research and development of new drugs and clinical products; Analysis of materials; Chemical analysis; Laboratory services; Laboratory testing; Medical laboratory services; Information and advisory services relating to the foregoing, including such services provided on-line from a computer network or the Internet; Research and development services for pharmaceuticals and for the treatment of diseases and injuries; Genetic engineering services; Genetic research; Scientific and technological services and research and development relating thereto; Scientific research in the field of genetics; Medical and pharmacological research services; Research and Development in relation to the following fields: Scientific, medical and industrial research and development services; Information and advisory services relating to the aforementioned, including such services provided on-line via a computer network or the Internet; research and development in the fields of biotechnology, biopharmaceuticals and gene therapy; Clinical trials; Research and Development in relation to the followig goods: Pharmaceutical goods, Vaccines and Medicines; Stem cell research; Research and development in the field of microorganisms and cells; Research in the field of gene therapy; Advisory services relating to gene therapy research; Biological research, clinical research and medical research; Product development; Biological development services; Consultancy relating to pharmaceutical research and development; Providing of scientific information in the field of medical disorders and the treatment thereof; Pharmaceutical research and development; Scientific services relating to the isolation and culture of human tissues and cells; Research relating to molecular sciences; Analysis in the field of molecular biology; Contract research services relating to molecular sciences
ID: 11018797416